Propanc Biopharma (PPCBD) Stock Statistics & Valuation Metrics

Propanc Biopharma has a market cap or net worth of $103.76K. The enterprise value is ―.

Propanc Biopharma has 15,372 shares outstanding. The number of shares has decreased by -2.65% in one year.

Propanc Biopharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Propanc Biopharma is ―. Propanc Biopharma’s PEG ratio is ―.

In the last 12 months, Propanc Biopharma had revenue of 0.00 and earned -1.82M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -607.98K and capital expenditures 0.00, giving a free cash flow of -607.98K billion.

Propanc Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Propanc Biopharma upcoming earnings date is May 15, 2020, TBA Not Confirmed.

Propanc Biopharma as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Propanc Biopharma has paid -129.13K in taxes.

Propanc Biopharma EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Propanc Biopharma has $14.63K in cash and marketable securities with $667.64K in debt, giving a net cash position of $653.01K billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Propanc Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―